Sanofi Q1 2013 - Interview with CFO Jérôme Contamine

Sanofi Q1 2013 - Interview with CFO Jérôme Contamine

PARIS--(BUSINESS WIRE)-- Sanofi, a global and diversified healthcare leader, reports earnings for the first-quarter of 2013. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and outlook.

Click to watch the video: http://bit.ly/101e4XC

Topics covered in the interview include:

- Performance

- Guidance

- Emerging Markets

- Diabetes

- Rare Diseases

- Multiple Sclerosis

- R&D Pipeline

- Capital Allocation

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY  ) .

Company website: www.sanofi.com



Sanofi
Investor Relations
Sébastien Martel, +33 1 53 77 45 45
IR@sanofi.com
or
Media Relations
+33 1 53 77 45 02
MR@sanofi.com

KEYWORDS:   Europe  France

INDUSTRY KEYWORDS:

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2402678, ~/Articles/ArticleHandler.aspx, 7/23/2014 4:21:15 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...